"Making Science Computable"
The Covid-19 Knowledge Accelerator is now the Health Evidence Knowledge Accelerator!
Content and support tools for making science computable and facilitating HEvKA projects can be found on the Fast Evidence Interoperability Resources (FEvIR) Platform.
The FEvIR HEvKA Project Page can be found at https://fevir.net/resources/Project/29272 and includes examples of evidence-related resources in current (R5) FHIR format.
Background Color | ||
---|---|---|
| ||
Watch 3 minute Lightning Talks From MCBK 2022 |
Click on the images below to be redirected to each 3 minute lightening talk!
Click on the images below for introductory information about HEvKA
Handy Cards | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||||||||
|
Email balper@computablepublishing.com to be added to the HEvKA distribution list (daily email update of HEvKA activities)
Join an expert working group for code system development -- see Invitation to join Expert Working Group.
Join us at any of the meetings listed on the left side of the screen by clicking on the following link:
Join Microsoft Teams Meeting (see meeting schedule below)
We look forward to seeing you there!
Background Color | ||
---|---|---|
| ||
Weekly Meeting Schedule |
Day | Time (Eastern) | Team |
---|---|---|
Monday | 8-9 am | Project Management Working Group |
Monday | 9-10 am | Setting the SRDR Platform on FHIR WG |
Monday | 10-11 am | Research on FHIR Working Group |
Tuesday | 9-10 am | Measuring the Rate of Scientific Transfer Working Group (SKAF Board Meets Last Tuesday of Month) |
Tuesday | 11am-12 pm | FEvIR Metadata Framework Working Group |
Tuesday | 1-2 pm | Statistic Standard and Terminology Working Group |
Tuesday | 2-3 pm | Research Design Working Group |
Wednesday | 8-9 am | Knowledge Ecosystem Liaison Working Group |
Thursday | 8-9 am | EBMonFHIR Implementation Guide WG (a CDS EBM sub-WG) |
Thursday | 9-10 am | Computable EBM Tools Development WG |
Thursday | 4-5 pm | Project Management Working Group |
Friday | 8-9 am | GRADE Terminology Working Group Meeting |
Friday | 9-10 am | Risk of Bias Terminology and Tooling Working Group |
Friday | 10-11 am | Communications (Awareness, Scholarly Publications) WG |
Friday | 12-1 pm | Eligibility Criteria Working Group |
You are welcome to join us!
Please email balper@computablepublishing.com with any questions.
For all of the above meetings: Join Microsoft Teams Meeting
+1 929-346-7156 United States, New York City (Toll)
Conference ID: 324 918 025#
Meeting support by Computable Publishing LLC
Background Color | ||
---|---|---|
| ||
Schedule and Agenda for the week: |
Monday, January 30February 6:
- 8 am Eastern: Project Management – review FHIR Trackers and IG preparations
- 9 am Eastern: Setting the SRDR Platform on FHIR Working Group – review API coordination between SRDR and FEvIRFEvIR: SRDR+ Project Importer
- 10 am Eastern: ResearchOnFHIR Working Group – continue learning about FHIRPath and CQL
Tuesday, January 31February 7:
- 9 am Eastern: Scientific Knowledge Accelerator Foundation Board of Directors – consider “Measuring Measuring the Rate of Scientific Knowledge Transfer Working Group”Group – initial metrics development protocol
- 11 am Eastern: FEvIR Metadata Framework Working Group – develop Profile representation on FEvIR Platform
- 1 pm Eastern: Statistic Standard and Terminology (new time) – continue review of related terms for the represent Measures of Dispersion in Evidence Resource model and Scientific Evidence Code System, attention to Measures of Dispersion terms
- 2 pm Eastern: Research Design Working Group – continue drafting article for submission review in-form-for-submission draft article for peer-reviewed publication
Wednesday, February 1February 8:
- 8 am Eastern: Knowledge Ecosystem Liaison Working Group – attention to guideline updating with MAGIC
- 12 pm Eastern: HL7 Clinical Decision Support Work Group - agenda may include EBMonFHIR Trackers
Thursday, February 2February 9:
- 8 am Eastern: EBM Implementation Guide Working Group (HL7 CDS EBMonFHIR sub-WG) – Create Profiles StudyOutcomeEvidence Profile of Evidence Resource
- 9 am Eastern: Computable EBM Tools Development Working Group – review FEvIR™: ActivityDefinition Adaptation Builder/Viewer and editing by datatype
- 12 pm Eastern: HL7 Biomedical Research and Regulation Work Group - FHIR Representation of Eligibility Criteria for Clinical Trials project – consider Characteristic Resource1 pm Eastern: GRADE Vocabulary Working Group (new time) – Drafting Terminology Development Protocol
- 4 pm Eastern: Project Management – prepare weekly agenda
Friday, February 3:February 10:
- 8 am Eastern: GRADE Vocabulary Working Group – Continue GRADE Vocabulary Development Methods Protocol from step 6
- 9 am Eastern: Risk of Bias Terminology and Tooling Working Group – continue review and addition of terms and definitions to the Scientific Evidence Code System; attention to Selective Reporting Bias terms
- 10 am Eastern: Communications Working Group – review progress on publications, presentations, and website
- 12 pm Eastern: Eligibility Criteria Working Group – review of – review of Characteristic Resource and/or Eligibility Criteria Matching Software Library and/or Characteristic Resource
Background Color | ||
---|---|---|
| ||
Participation Opportunities |
Background Color | ||
---|---|---|
| ||
See an Example of a JSON FHIR Resource |
- EXAMPLES showcasing current FHIR format include:
- Evidence Resource (meta-analysis finding) at https://fevir.net/resources/Evidence/55, corresponding Citation Resource at https://fevir.net/resources/Citation/58
- Evidence Resource (randomized trial finding) at https://fevir.net/resources/Evidence/7637, corresponding Citation Resource at https://fevir.net/resources/Citation/7638
- EvidenceReport Resource (“COKA-EBM Clinical Outcomes in ACTT-1 Remdesivir RCT EvidenceReport”) at https://fevir.net/resources/EvidenceReport/156 fully supported with 9 Evidence Resources, 7 EvidenceVariable Resources, 2 Group Resources, and 1 ActivityDefinition Resource
- EvidenceReport Resource (“Anticoagulation for Non-critically ill COVID-19 Multiplatform RCT EvidenceReport”) at https://fevir.net/resources/EvidenceReport/18816
- EvidenceReport Resource (“Anticoagulation for Non-critically ill COVID-19 Individual RCTs Table EvidenceReport”) at https://fevir.net/resources/EvidenceReport/18831
- EvidenceReport Resource (“Anticoagulation for Non-critically ill COVID-19 Summary of Findings from RCTs Table EvidenceReport”) at https://fevir.net/resources/EvidenceReport/18881
Background Color | ||
---|---|---|
| ||
...